Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial

Bibliographic Details
Main Authors: Allenbach, Yves, Guiguet, Marguerite, Rigolet, Aude, Marie, Isabelle, Hachulla, Eric, Drouot, Laurent, Jouen, Fabienne, Jacquot, Serge, Mariampillai, Kuberaka, Musset, Lucile, Grenier, Philippe, Devilliers, Herve, Hij, Adrian, Boyer, Olivier, Herson, Serge, Benveniste, Olivier
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634756/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634756/

Similar Items